Clinical Trial Update: A Phase IV Safety and Efficacy Study of VI-0521 in Adolescents With Obesity [Phase 4]

View source ↗

Summary

Phase IV safety and efficacy study of VI-0521 in adolescents with obesity has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adolescent Obesity
• Obesity in Adolescents

Drugs mentioned

• VI-0521

Snippet

Sponsor: VIVUS LLC | Conditions: Adolescent Obesity, Obesity in Adolescence | Phase 4 | Status: COMPLETED | Results posted: 2022-09-10